Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by our partner Reaxense.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
We employ our advanced, specialised process to create targeted libraries for receptors.
Fig. 1. The sreening workflow of Receptor.AI
This includes comprehensive molecular simulations of the receptor in its native membrane environment, paired with ensemble virtual screening that factors in its conformational mobility. In cases involving dimeric or oligomeric receptors, the entire functional complex is modelled, pinpointing potential binding pockets on and between the subunits to capture the full range of mechanisms of action.
Key features that set our library apart include:
partner
Reaxense
upacc
Q14957
UPID:
NMDE3_HUMAN
Alternative names:
Glutamate [NMDA] receptor subunit epsilon-3; N-methyl D-aspartate receptor subtype 2C
Alternative UPACC:
Q14957; B2RTT1
Background:
The Glutamate receptor ionotropic, NMDA 2C, also known as Glutamate [NMDA] receptor subunit epsilon-3 and N-methyl D-aspartate receptor subtype 2C, plays a pivotal role in neural communication. It is a component of NMDA receptor complexes, crucial for high calcium permeability and voltage-dependent sensitivity to magnesium. Activation of this receptor is essential for synaptic plasticity, contributing to learning and memory by regulating excitatory and inhibitory activities in the prefrontal cortex.
Therapeutic significance:
Understanding the role of Glutamate receptor ionotropic, NMDA 2C could open doors to potential therapeutic strategies.